Table 2.
Variables | SES (n = 21) |
BES (n = 23) |
Total (n = 44) |
p-value | |
---|---|---|---|---|---|
Gender (male) | 17 (81%) | 17 (74%) | 34 | 0.724 | |
Age (> 65) | 5 (24%) | 6 (26%) | 11 | 0.862 | |
Symptom onset (≤2 days) | 2 (9%) | 0 (0%) | 2 | 0.222 | |
Initial NIHSS (≥4) | 5 (24%) | 3 (13%) | 8 | 0.448 | |
Presenting symptom pattern |
Stroke | 14 (66%) | 16 (70%) | 30 | 0.837 |
TIA | 7 (33%) | 7 (30%) | 14 | ||
Risk factors | Hypertension | 18 (86%) | 15 (65%) | 33 | 0.117 |
Diabetes mellitus | 7 (33%) | 11 (48%) | 18 | 0.388 | |
Hyperlipidaemia | 12 (57%) | 8 (34%) | 20 | 0.137 | |
Smoking | 7 (33%) | 6 (26%) | 13 | 0.599 | |
Cardiac disease | 5 (24%) | 1 (4%) | 6 | 0.088 | |
Previous stroke | 3 (14%) | 7 (30%) | 10 | 0.287 | |
Location | Intracranial ICA | 0 (0%) | 10 (43%) | 10 | 0.001 |
M1 | 17 (81%) | 5 (22%) | 22 | < 0.001 | |
Intracranial VA | 3 (14%) | 7 (30%) | 10 | 0.287 | |
Basilar artery | 1 (5%) | 1 (4%) | 2 | 1.000 | |
Adverse event in 6 m | 1 (5%) | 0 (0%) | 1 | 0.477 | |
mRS (≤2) at 6 m | 21 (100%) | 23 (100%) | 44 | – | |
Residual stenosis | 4-47(32) | 0-47(18) | 0-47(25) | < 0.001 | |
Restenosis | 4/9 (44%) | 1/10 (10%) | 5/19 | 0.327 | |
SES = self-expandable stent, BES = balloon-expandable stent, NIHSS = National Institutes of Health Stroke Scale, TIA = transient ischemic attach, ICA = internal carotid artery, VA = vertebral artery, mRS = modified Rankin Scale, m = months. |